ETFs
I
INCY
Incyte Corp
124.65
-0.66-0.53%Pre Market: 124.21 -0.44 -0.35%05:29 09/22 EDT
OPEN/PREV CLOSE124.72/124.65
TODAY RANGE124.02-127.36
VOL396.60K
MARKET CAP25.74B
52 WEEK RANGE81.09-132.60
AVG VOL (3M)1.66M
% TURNOVER0.20%
TURNOVER--
P/E (TTM)16.18
% RANGE2.68%
EPS(TTM)7.85
P/E(FORWARD)56.68
P/B4.023
BVPS31.57
DIVIDEND--
P/S4.902
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP25.23B
SHARES OUTSTANDING202.70M
NEXT EARNINGS10/26-10/30
FREE FLOAT198.70M
LOT SIZE1
EX-DATE09/01/2000
News
Press Releases
Financial Reports
Profile
Benzinga·8h ago
Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Seeking Alpha·1d ago
Specialised Therapeutics to commercialize Incyte’s Opzelura in Australia
Seeking Alpha·2d ago
FDA, Duke-Margolis workshop to examine evidence standards for rare diseases
Simply Wall St·2d ago
Does Earlier MINJUVI Access Change The Bull Case For Incyte (INCY)?
TipRanks·3d ago
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
Simply Wall St·4d ago
Incyte (INCY) Looks Fully Valued As Ontario Backs MINJUVI Access
Seeking Alpha·5d ago
Tracking Baker Brothers' Portfolio: Q2 2026 Update
Same Industry
Name/Symbol
Change%
Price